Navigation Links
Cipro Has Cheaper Cousins to Treat Anthrax

Cipro, Cipro, Cipro. That's been the mantra of the media as dozens of people exposed to anthrax -- and thousands who weren't -- clamor for the potent antibiotic. But if the supply dwindles, doctors say other cheaper and widely available medications can be used, including a previous generation's wonder drug: penicillin. Although alternatives exist, Cipro is the latest and greatest, so it tends to get attention. //

It helped that Cipro was the only drug approved by the Food and Drug Administration to treat inhaled anthrax. But Health and Human Services Secretary Tommy Thompson today encouraged the use of two other antibiotics, penicillin and doxycycline. Before this month, Cipro -- the brand name for the drug ciprofloxacin -- was little known outside of doctor's offices and pharmacies, where it is dispensed to treat a variety of diseases, including urinary tract infections.

Like other antibiotics, Cipro kills harmful bacteria in the body. The main difference is that it's designed to attack a variety of types of germs. It is effective against a wide range of organisms. Doctors sometimes use Cipro when they are waiting to find out exactly what type of bacteria they're dealing with. It's especially effective against anthrax because it may take days for scientists to discover what kind of strain is involved in an attack.

According to experts, all known strains are vulnerable to Cipro, although the drug must be given before symptoms develop or shortly thereafter to be most effective. Before Cipro came along, penicillin was a common treatment for anthrax. Pharmaceutical companies say they're ready to ramp up production of anti-anthrax drugs if needed.


'"/>




Page: 1

Related medicine news :

1. Once-Daily Cipro(R) XR for Treating Complicated Urinary Tract Infections
2. Small Cars, Anti-AIDS And Anti-Cancer Drugs Would Be Cheaper
3. Cheaper Vaccines From Tomatoes To Fight HIV, Hepatitis B
4. Diabetics to get Relief from Cheaper Drugs
5. Cheaper and Quicker Alternative to Ovarian Reserve Tests
6. Cousins Recovering from His Substance Abuse Problem
7. Advances in Treatment of Cataracts
8. Recommendations for Treatment of Blood Pressue
9. New FDA Approved Drug To Treat Migraine
10. Treatment for Menieres disease
11. Treatment for pre-menstrual syndrome is ineffective
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2017)... ... ... Maury Regional Health has announced a large-scale adoption of AccuVein vein visualization ... Regional Medical Center is making vein visualization part of their standard of care. , ... importantly, helps our staff members locate a vein that will provide good access to ...
(Date:8/16/2017)... ... August 16, 2017 , ... A global leader in the treatment ... clinics in all 29 Indian states—bringing the country one step closer to eliminating clubfoot ... the nonprofit organization is on track to enroll 10,000 children in the clubfoot treatment ...
(Date:8/16/2017)... ... , ... Fusion Flix Inc., a Telly Award Winning, Non Profit Corporation has ... viewers in a partnership with the Amazon Video Direct Streaming Distribution Platform. , Their ... Ray disc in 2018. Proceeds will be going to further health research. , ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... TopConsumerReviews.com recently ... Lab Testing . , The healthcare industry in the United States has undergone ... are the days of needing to have a doctor’s order to get a blood ...
(Date:8/16/2017)... , ... August 16, 2017 , ... First Choice ... States, named Dr. Douglas J. Harrison, as the new Medical Director of its Sienna ... new facility Medical Director of our Sienna Plantation location,” said Dr. Michael (Derek) Caraway, ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017  AOTI Inc. announced today that its ... Inc., has recently opened a New York City Office in ... of its unique Topical Wound Oxygen (TWO 2 ) homecare therapy. ... Accreditation Commission for Health Care (ACHC) under the company,s DMEPOS accreditation ... ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... Mich. , Aug. 7, 2017 Diplomat Pharmacy, ... of Joel Saban as president, effective Aug. 7, ... Urick has decided to pursue other interests and will ... "During his tenure, Paul has served us in multiple leadership ... Specialty Pharmacy in Jun. 2015 and has provided decisive, strategic ...
Breaking Medicine Technology: